NIM
RLAY icon

NEOS Investment Management’s Relay Therapeutics RLAY Stock Holding History

NEOS Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,230
Closed -$958K – 642
2025
Q4 		$958K Buy
113,230
+19,765
+21% +$141K 0.01% 558
2025
Q3 		$488K Sell
93,465
-3,685
-4% -$14.1K ﹤0.01% 579
2025
Q2 		$336K Buy
97,150
+8,040
+9% +$23.9K ﹤0.01% 576
2025
Q1 		$233K Buy
89,110
+24,455
+38% +$95.8K ﹤0.01% 576
2024
Q4 		$266K Buy
64,655
+6,365
+11% +$34.6K 0.01% 562
2024
Q3 		$413K Buy
58,290
+3,685
+7% +$27.5K 0.01% 515
2024
Q2 		$356K Buy
54,605
+31,825
+140% +$217K 0.01% 505
2024
Q1 		$189K Buy
22,780
+670
+3% +$6.54K 0.01% 555
2023
Q4 		$243K Buy
+22,110
New +$187K 0.02% 453

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return